SANCUSO
Active substance: granisetron
PATCH · GRANISETRON 3.1 mg/24h
United StatesActive
Marketing holder: Cumberland Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- GRANISETRON · 3.1 mg/24h
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-8f5f-7bc9-8d89-9b61f515d2bc,01a1208c-af40-7ef4-a55f-9099fe3d6323,01a1208d-3b02-76f9-bf35-d87cee8885ef,01a1208d-70ec-7d51-95d9-e0b6b8790b11,01a1208d-7bce-7ddc-960a-2a0b3b685157;count=14 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 66220-637
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- TRANSDERMAL
Sources
- product · openFDA NDC · 66220-637 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 66220-637 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 66220-637 · Verified 2026-10-09 · open in source